Minerva Neurosciences (NERV) Invested Capital (2013 - 2017)

Minerva Neurosciences' Invested Capital history runs 5 years deep, the most recent figure standing at $3.5 million for Q4 2017.

• Quarterly Invested Capital fell 58.59% year-over-year to $3.5 million in Q4 2017, while the trailing twelve-month figure through Sep 2018 was $3.5 million (down 86.79% YoY) and the FY2017 annual result came in at $3.5 million, down 58.59% from the prior year.
• Invested Capital was $3.5 million for Q4 2017 at Minerva Neurosciences, down from $4.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $10.0 million in Q2 2015 and bottomed at $2.0 million in Q4 2013.
• A 5-year average of $7.2 million and a median of $8.4 million in 2016 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2015 — Invested Capital surged 402.07% — and 2017, when it plunged 58.59%.
• Minerva Neurosciences' Invested Capital stood at $2.0 million in 2013, then increased by 0.92% to $2.0 million in 2014, then jumped by 402.07% to $10.0 million in 2015, then fell by 15.71% to $8.4 million in 2016, then plunged by 58.59% to $3.5 million in 2017.
• Business Quant data shows NERV's Invested Capital at $3.5 million in Q4 2017, $4.8 million in Q3 2017, and $6.0 million in Q2 2017.